Four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification under a new brand: BlueRidge Life Sciences.
BlueRidge Life Sciences is a growing family of companies that provides a comprehensive suite of life sciences services, spanning toxicology, regulatory science, risk assessment, epidemiology, biostatistics, engineering, clinical research, health economics, pharmaceutical commercialisation, and environmental consulting.
Across these specialised areas, we collaborate to deliver science-driven solutions that support industries including pharmaceuticals, biotechnology, medical devices, chemicals, foods and consumer products. Our collective expertise helps clients navigate regulatory requirements, assess safety and efficacy, manage risks, and optimise commercialisation strategies.
“Our vision with BlueRidge Life Sciences is to serve as a single source for a broad range of specialised scientific services that support our clients’ life science objectives and solve their technical or regulatory challenges,” said Renaat Van den Hooff, Executive Board Chairman of BlueRidge Life Sciences. “We leverage our innovative methodologies, advanced technology, and multidisciplinary expertise to help clients make informed decisions about human and environmental health issues, rooted in sound science and high integrity.”
For more information, visit blueridgelifesciences.com.